Defining Optimal Treatment Times in Head and Neck Cancer Care: What Are We Waiting For?

Jeffrey J Houlton

Abstract readComment

In one paragraph

Article in JAMA otolaryngology-- head & neck surgery, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it

0cells of the map it votes in

5citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

Efficacy of ketamine mouthwash in the management of oral and pharyngeal toxicity associated with head and neck chemoradiotherapy: protocol for a phase II, Simon's two-stage trial.BMJ open · 2023
Article
Development and Evaluation of a Navigation-Based, Multilevel Intervention to Improve the Delivery of Timely, Guideline-Adherent Adjuvant Therapy for Patients With Head and Neck Cancer.JCO oncology practice · 2021
Article
The Evolution of Care of Cancers of the Head and Neck Region: State of the Science in 2020.Cancers · 2020
Review
Development and Validation of Nomograms for Predicting Delayed Postoperative Radiotherapy Initiation in Head and Neck Squamous Cell Carcinoma.JAMA otolaryngology-- head & neck surgery · 2020
Article
Strategic Reduction of Package Time in Head and Neck Cancer.Advances in radiation oncology
Article

4 · The record

Corrections and comments

Comment on
Association of Treatment Delays With Survival for Patients With Head and Neck Cancer: A Systematic Review.2019

5 · Who and what money

Authors and funding

1 author.

Jeffrey J HoultonDepartment of Otolaryngology-Head and Neck Surgery, University of Washington Medical Center, Seattle.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Head and Neck NeoplasmsTime-to-TreatmentHumansTime Factors

Identifiers

PMID30383147

DOI10.1001/jamaoto.2018.2838

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.